We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Akebia Therapeutics Inc is a biopharmaceutical company. It focuses on the development and commercialization of novel therapeutics to patients with kidney disease through hypoxia-inducible factor (HIF) biology. Its lead product candidate is Vadadustat, an oral therapy, which is used for the treatment... Akebia Therapeutics Inc is a biopharmaceutical company. It focuses on the development and commercialization of novel therapeutics to patients with kidney disease through hypoxia-inducible factor (HIF) biology. Its lead product candidate is Vadadustat, an oral therapy, which is used for the treatment of anemia related to chronic kidney disease in non-dialysis and dialysis patients. The company is also developing a HIF-based portfolio of product for the treatment of anemia. Geographically, all the business activity is functioned through the region of United States. Show more
Akebia Therapeutics to Present at the Jefferies Global Healthcare Conference PR Newswire CAMBRIDGE, Mass., May 23, 2024 CAMBRIDGE, Mass., May 23, 2024 /PRNewswire/ -- Akebia Therapeutics®, Inc...
Akebia Therapeutics to Present at the 2nd Annual HCW Bioconnect Investor Conference PR Newswire CAMBRIDGE, Mass., May 14, 2024 CAMBRIDGE, Mass., May 14, 2024 /PRNewswire/ -- Akebia Therapeutics®...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0531 | -4.65789473684 | 1.14 | 1.16 | 1.06 | 2120552 | 1.10994761 | CS |
4 | -0.2231 | -17.0305343511 | 1.31 | 1.56 | 1.03 | 3057418 | 1.25694142 | CS |
12 | -0.5131 | -32.06875 | 1.6 | 2.48 | 1.03 | 5219050 | 1.63637208 | CS |
26 | 0.0969 | 9.78787878788 | 0.99 | 2.48 | 0.9515 | 3456850 | 1.58028285 | CS |
52 | -0.1731 | -13.7380952381 | 1.26 | 2.48 | 0.7801 | 2576393 | 1.44482986 | CS |
156 | -2.4731 | -69.4691011236 | 3.56 | 4.33 | 0.241 | 3780890 | 1.27268517 | CS |
260 | -4.1631 | -79.2971428571 | 5.25 | 13.78 | 0.241 | 3514315 | 2.38763377 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions